OSE Immunotherapeutics
OSE | PA
Overview
Corporate Details
- ISIN(s):
- FR0012127173 (+2 more)
- LEI:
- 969500HIUWVGY6NZSM05
- Country:
- France
- Address:
- 22 BOULEVARD BENONI GOULLIN, 44200 NANTES
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
OSE Immunotherapeutics is a clinical-stage biotechnology company specializing in the development of first-in-class immunotherapies for immuno-oncology (IO) and immuno-inflammation (I&I). The company's work focuses on controlling the immune system through therapies that activate or regulate T-cells. Its integrated model encompasses target identification, product candidate generation, and early- to mid-stage clinical development, supported by three proprietary drug discovery platforms. OSE Immunotherapeutics advances its pipeline through strategic partnerships and out-licensing agreements with international pharmaceutical, clinical, and academic collaborators.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for OSE Immunotherapeutics.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-17 18:30 |
Regulatory News Service
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
|
English | 201.6 KB | |
| 2025-07-17 18:30 |
Report Publication Announcement
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
|
French | 212.2 KB | |
| 2025-06-20 19:30 |
Legal Proceedings Report
OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene…
|
English | 226.5 KB | |
| 2025-06-20 19:30 |
Pre-Annual General Meeting Information
OSE Immunotherapeutics réaffirme son engagement à tenir une Assemblée Générale …
|
French | 204.2 KB | |
| 2025-06-11 18:30 |
Regulatory News Service
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025
|
French | 201.6 KB | |
| 2025-06-11 18:30 |
Pre-Annual General Meeting Information
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
|
English | 204.6 KB | |
| 2025-06-09 08:00 |
Pre-Annual General Meeting Information
MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE
|
French | 178.6 KB | |
| 2025-06-09 08:00 |
Pre-Annual General Meeting Information
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
|
English | 184.3 KB | |
| 2025-06-05 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations relatives au nombre total de droits de vote et d’actions composan…
|
French | 196.4 KB | |
| 2025-06-04 08:00 |
Pre-Annual General Meeting Information
Ose Immunotherapeutics : Mise à disposition des documents préparatoires à l’Ass…
|
French | 174.9 KB | |
| 2025-06-04 08:00 |
Investor Presentation
OSE Immunotherapeutics renforce sa stratégie de croissance : Accélération des …
|
French | 791.9 KB | |
| 2025-06-04 08:00 |
Pre-Annual General Meeting Information
Ose Immunotherapeutics : Documents made available to the shareholders for the c…
|
English | 222.3 KB | |
| 2025-06-04 08:00 |
Business and Financial Review
OSE Immunotherapeutics strengthens Growth Strategy: Accelerates key pillars of…
|
English | 290.7 KB | |
| 2025-06-02 18:00 |
Regulatory News Service
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Va…
|
English | 333.0 KB | |
| 2025-06-02 18:00 |
Earnings Release
OSE Immunotherapeutics fait un point clinique sur Tedopi®, vaccin contre le can…
|
French | 311.0 KB |
Automate Your Workflow. Get a real-time feed of all OSE Immunotherapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for OSE Immunotherapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-19 | N/A | Other | Other | 10,000 | 35,700.00 EUR |
| 2024-06-17 | N/A | Other | Other | 10,000 | 35,800.00 EUR |
| 2024-06-17 | N/A | Other | Other | 10,000 | 35,700.00 EUR |
| 2024-06-13 | N/A | Other | Sell | 6,369 | 45,879.09 EUR |
| 2024-06-03 | N/A | Other | Sell | 40,000 | 314,512.00 EUR |
